US 11639504
Methods and compositions for regulation of transgene expression
granted A61PA61P1/16A61P11/00
Quick answer
US patent 11639504 (Methods and compositions for regulation of transgene expression) held by Sangamo Therapeutics, Inc. expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P17/00, A61P3/00